Skip to main content

Invesco Ltd: Form 8.3 – Loungers PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Loungers PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

Invesco Ltd: Form 8.3 – Direct Line Insurance Group PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Direct Line Insurance Group PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable...

Continue reading

Medical Robots Market to Witness Massive Growth at USD 34.32 Billion by 2031 | SkyQuest Technology

Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the medical robot market will attain a value of USD 34.32 Billion by 2031, with a CAGR of 17.4 % during the forecast period (2024-2031). The rising incidence of diseases such as cancer, neurological disorders, and orthopedic neck & spine conditions will create demand for accuracy surgical procedures particularly in the aging population segment, fueling medical robots market growth. Increasing numbers of geriatric patients undergoing surgical procedures also boosts market growth. Ideal for patients and healthcare professionals alike, robotic surgical procedures offer better advantages over traditional open surgeries that can include less pain, shorter recovery times, and decreased complication rates. Compared to traditional techniques, robotic systems provide...

Continue reading

Smart Materials Market Size is Poised to Grow with CAGR of 13.5% by 2031 | SkyQuest Technology

Smart Materials Market size was valued at USD 70.06 billion in 2022 and is poised to grow from USD 79.51 billion in 2023 to USD 218.98 billion by 2031, growing at a CAGR of 13.5% in the forecast period (2024-2031). Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the smart materials market will attain a value of USD 218.98 Billion by 2031, with a CAGR of 13.5% over the forecast period (2024-2031). Smart materials are increasingly being applied to age-oriented products targeting the aged population. Besides that, such products help make lives easier for the aged in easy routine activities. The population proportion of the age group will increase much in the future; it increases demand for smart material products. In addition, the adoption of smart materials is increasing massively across a wide variety of end-user...

Continue reading

Preparative and Process Chromatography Market to Augment Growth at USD 24.15 Billion by 2031 | SkyQuest Technology

Large-scale integration of liquid chromatography techniques in downstream processing has accelerated the growth of this field. Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Preparative and Process Chromatography Market will attain a value of USD 24.15 Billion by 2031, with a CAGR of 11.7% during the forecast period (2024-2031). The major factors that are boosting preparative and process chromatography market growth are the increasing demand and acceptance of monoclonal antibodies in the pharmaceutical and biotechnology markets. Moreover, increasing biopharmaceutical industries, rising demand for cost-efficient processes, and rising popularity for advanced purification techniques are propelling the market. Technological advancements and innovations in chromatography products are some crucial factors...

Continue reading

Cell Counting Market to Evolve at a Modest 6.8% CAGR through 2031 | SkyQuest Technology

The cell counting market is speedily progressing on the back of the growing amount of research in cell biology, cancer research, and immunology. Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the cell counting market size will attain a value of USD 17.72 billion by 2031, with a CAGR of 6.8% over the forecast period (2024-2031). Growing investments in medical research around the world and advancements in cell counting technologies are slated to be key factors driving the cell counting market growth in the future. Providing efficient cell functionality and viability evaluation is expected to present new opportunities for cell counting providers in the long run. Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/cell-counting-market Browse in-depth TOC on “Cell...

Continue reading

Blood Culture Tests Market is Slated to Evolve at an Impressive 12.3% CAGR through 2031 | SkyQuest Technology

This process includes extraction of a sample of blood and placing it in a sterile setting that is helpful for the development of these microorganisms. Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the blood culture tests market size will attain a value of USD 17.50 billion by 2031, with a CAGR of 12.3% over the forecast period (2024-2031). Rising incidence of bloodstream infections and a growing number of surgical procedures performed around the world are expected to bolster the blood culture tests market growth over the coming years. Spreading awareness regarding the benefits of blood culture tests and use of advanced technologies are expected to generate new opportunities in the future. Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/blood-culture-tests-market Browse...

Continue reading

HSBC Bank Plc – Form 8.5 (EPT/RI) – Loungers plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”) 1.         KEY INFORMATION(a) Name of exempt principal trader: HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates:     Use a separate form for each offeror/offeree Loungers plc(c) Name of the party to the offer with which exempt principal trader is connected: OFFEROR: CF Exedra Bidco Limited (a newly formed company indirectly owned by funds and accounts managed or advised by affiliates of Fortress Investment Group, LLC)(d) Date dealing undertaken: 28 November 2024(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect...

Continue reading

Form 8.3 – AXA INVESTMENT MANAGERS: Loungers plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Loungers plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

Pluxee acquires Beneficio Facil in Brazil and reinforces its employee mobility offer

Pluxee acquires Benefício Fácil in Brazil and reinforces its employee mobility offer Pluxee to reinforce its strong position in Brazil by acquiring 100% of Benefício Fácil, a Brazilian provider of employee mobility benefits Transaction accretive to Recurring EBITDA margin at Group level from the first year Operation to be fully funded from existing financial resourcesParis: November 29, 2024 // Pluxee (the “Group”), a global player in Employee Benefits and Engagement, today announces that it has signed an agreement to acquire 100% of Benefício Fácil, a provider of mobility solutions for public transport in Brazil, a growing and underpenetrated market in which mobility benefits for employees are mandatory. The agreement is subject to approval from the Central Bank of Brazil (BACEN). With this new acquisition, Pluxee continues to deliver...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.